REQUEST A DEMO
Total
USD $0.00
Search more companies

Phoenix Pharma Polska Sp. z o.o. (Poland)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Phoenix Pharma Polska Sp. z o.o. Profile Updated: June 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

PHOENIX Pharma Poland Sp. z o. o. is part of one of Europe's largest pharmaceutical distribution companies PHOENIX Pharmahandel GmbH & Co. KG, known for its mercantile integrity, and respect of the European Union of Good Distribution Practice, modern high culture of the organization and with partners. As a result of internal organizational changes within the context of PHOENIX Pharma AG, February 1, 2006 PHOENIX Pharma shares were transferred to Poland Tamro Group. Tamro Group is a leading pharmaceutical wholesaler in Northern Europe (Scandinavia, Finland and the Baltic States), the leading retail operations in Norway, Estonia, Latvia, Lithuania and Poland. The average share of Tamro in the wholesale pharmaceutical market in the Nordic countries is around 52%.

Headquarters
Ul. Rajdowa 9
Konotopa; Mazowieckie; Postal Code: 05-850

Contact Details: Purchase the Phoenix Pharma Polska Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Phoenix Pharma Polska Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Phoenix Pharma Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Phoenix Pharma Polska Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Phoenix Pharma Polska Sp. z o.o. report to view the information.
Incorporation Date:
August 10, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Phoenix Pharma Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
5.89%
Total operating revenue
5.89%
Operating profit (EBIT)
196.51%
EBITDA
46.81%
Net Profit (Loss) for the Period
54.33%
Total assets
10.19%
Total equity
9.15%
Operating Profit Margin (ROS)
0.75%
Net Profit Margin
0.54%
Return on Equity (ROE)
2.45%
Quick Ratio
0.07%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?